Research and Development

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …

Sigma-Aldrich has acquired clinical testing company BioReliance for $350 million. Purchased from Avista Capital Partners, BioReliance provides services that include …

Dietmar Leitner has been appointed managing director of Napp Pharmaceuticals, part of the Napp Pharmaceutical Group.   Dietmar has worked …

Pfizer has begun talks with a real estate investor to sell its R&D centre in Sandwich. The site was Pfizer’s …

GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will …

Boehringer Ingelheim is expanding the scope of its studies into afatinib to test its use against head and neck cancers. …

Amgen is to buy German biotech firm Micromet for $1.16 billion to broaden its mid-stage pipeline and consolidate its oncology …

Bristol-Myers Squibb has announced that its board has elected Gerald Storch to serve as a member of the audit committee, …

A new study of how clinical research associates (CRAs) spend their time has produced some interesting and surprising results. The …

Use of cell-based assay technology is set to grow rapidly over the next decade, helping to speed up drug discovery …

Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …